Vioxx Ruling A Boost For Securities Suits: Attys

Law360, New York (April 27, 2010, 6:58 PM EDT) -- The U.S. Supreme Court has ruled that the limitations period in securities suits doesn't begin until the plaintiff discovers, or a reasonable plaintiff would discover, facts constituting a violation of securities law, including scienter — a decision that attorneys say could lead to more securities suits.

The opinion, written by Justice Stephen Breyer and handed down Tuesday, is a victory for investors suing Merck & Co. Inc. for allegedly misleading them about risks of the now-withdrawn anti-inflammatory drug Vioxx. It affirms an earlier decision by the...
To view the full article, register now.